There are reports that TRPC5 knockout and TRPC5 inhibitors can reduce the severity of albuminuria and glomerulosclerosis in certain kidney disease models in rats and mice [45,46,47], suggesting that excessive TRPC5 function is pathogenic in glomeruli. The gene discussed is TRPC5; the disease is glomerulosclerosis.